Literature DB >> 1740697

Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.

J Okada1, K Yoshikawa, M Itami, K Imaseki, K Uno, J Itami, J Kuyama, A Mikata, N Arimizu.   

Abstract

To evaluate the relationship between PET using 18F-fluorodeoxyglucose (FDG) and pathological findings and to compare indices obtained by FDG-PET, FDG-PET was performed in 23 patients with untreated malignant lymphoma. Three indices obtained by FDG-PET, tumor-to-normal contrast ratio (TCR), distribution absorption ratio (DAR), k1k2/(k2 + k3), correlated with proliferative activity which was pathologically estimated both by mitotic count and by proportion of cells in all phases of the cell cycle. The relationship did not significantly change according to which of the three indices was chosen. FDG-PET, which shows the proliferative activity of tumors, is considered to be a useful method for managing tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740697

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  36 in total

Review 1.  Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Authors:  Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-22       Impact factor: 9.236

Review 2.  PET in lymphoma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

3.  A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.

Authors:  Y Ichiya; Y Kuwabara; M Sasaki; T Yoshida; J Omagari; Y Akashi; A Kawashima; T Fukumura; K Masuda
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

Review 4.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 5.  Non-Hodgkin Lymphoma Metabolism.

Authors:  Brian James Kirsch; Shu-Jyuan Chang; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

6.  (99m)Tc-EC-guanine: synthesis, biodistribution, and tumor imaging in animals.

Authors:  David J Yang; Kaoru Ozaki; Chang-Sok Oh; Ali Azhdarinia; Thomas Yang; Megumi Ito; Allison Greenwell; Jerry Bryant; Saady Kohanim; Vincenzo K Wong; E Edmund Kim
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

7.  Can nuclear medicine predict response to chemotherapy?

Authors:  J L Moretti; M Caglar; M Duran-Cordobes; J F Morere
Journal:  Eur J Nucl Med       Date:  1995-02

8.  Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.

Authors:  A Dimitrakopoulou-Strauss; L G Strauss; H Goldschmidt; W J Lorenz; W Maier-Borst; G van Kaick
Journal:  Eur J Nucl Med       Date:  1995-05

9.  Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.

Authors:  Carmen S Dence; Datta E Ponde; Michael J Welch; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2008-08       Impact factor: 2.408

10.  ⁹⁹mTc-N4amG: synthesis biodistribution and imaging in breast tumor-bearing rodents.

Authors:  Ning Tsao; Mithu Chanda; Dong-Fang Yu; Hiroaki Kurihara; Yin-Han Zhang; Richard Mendez; David J Yang
Journal:  Appl Radiat Isot       Date:  2012-10-11       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.